References
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- HalbertRJIsonakaSGeorgeDIqbalAInterpreting COPD prevalence estimates: what is the true burden of disease?Chest200312351684169212740290
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
- SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
- ConnorsAFJrDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care Med19961544 Pt 19599678887592
- VijayasarathaKStockleyRAReported and unreported exacerbations of COPD: analysis by diary cardsChest20081331344117989153
- Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- NeedhamMStockleyRAExacerbations in {alpha}1-antitrypsin deficiencyEur Respir J2005256992100015929953
- AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
- AaronSDVandemheenKLHebertPOutpatient oral prednisone after emergency treatment of chronic obstructive pulmonary diseaseN Engl J Med2003348262618262512826636
- CazzolaMMacNeeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
- Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2398S401S10843984
- JonesPWLamarcaRChuecosFCharacterisation and impact of reported and unreported exacerbations: results from ATTAINEur Respir J20144451156116525234803
- SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
- MiravitllesMEspinosaCFernandez-LasoEMartosJAMaldonadoJAGallegoMRelationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPDChest19991161404610424501
- Brusse-KeizerMGGrotenhuisAJKerstjensHARelation of sputum colour to bacterial load in acute exacerbations of COPDRespir Med2009103460160619027281
- SolerNEsperattiMEwigSHuertaAAgustiCTorresASputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPDEur Respir J20124061344135322523352
- GompertzSO’BrienCBayleyDLHillSLStockleyRAChanges in bronchial inflammation during acute exacerbations of chronic bronchitisEur Respir J20011761112111911491152
- GompertzSHillATBayleyDLStockleyRAEffect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiencyRespir Med200610061094109916257194
- StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest200011761638164510858396
- WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
- AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166